Laminin-5 gamma 2 chain expression is associated with intensity of tumor budding and density of stromal myofibroblasts in oral squamous cell carcinoma

Journal of Oral Pathology and Medicine

Volumn 43, Issue 3, 2014, Pages 199-204

  Marangon Junior, Helvécio ^a   Rocha, Valéria Nazaré ^a   Leite, Camila Ferreira ^a   de Aguiar, Maria Cássia Ferreira ^b   Souza, Paulo Eduardo Alencar ^a   Horta, Martinho Campolina Rebello ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Laminin 5 2; Myofibroblast; Oral squamous cell carcinoma; Tumor budding

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; KALININ; LAMININ 5 GAMMA 2 CHAIN; UNCLASSIFIED DRUG; ACTIN; KERATIN; LAMC2 PROTEIN, HUMAN; LAMININ;

ARTICLE; CELL BUDDING; CELL DENSITY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOUTH SQUAMOUS CELL CARCINOMA; MYOFIBROBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR MICROENVIRONMENT; ADULT; AGED; CELL COUNT; CHEMISTRY; FEMALE; MALE; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL COUNT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LAMININ; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MYOFIBROBLASTS; NEOPLASM INVASIVENESS;

EID: 84896316052     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12121     Document Type: Article

References (53)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer 2010; 127: 2893-917.
2. Barnes L, Eveson JW, Reichart P, et al. World Health Organization Classification of Tumours. Pathology and Genetics. Head and Neck Tumours. Albany: IARC press, 2005; 164-75.
3. Scully C. Oral cancer aetiopathogenesis; past, present and future aspects. Med Oral Patol Oral Cir Bucal 2011; 16: 306-11.
4. Krolls SO, Hoffman S. Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14.235 cases by age, sex, and race of patients. J Am Dent Assoc 1976; 92: 571-4.
5. Giannelli G, Antonaci S. Biological and clinical relevance of Laminin-5 in cancer. Clin Exp Metastasis 2001; 18: 439-43.
6. Hintermann E, Quaranta V. Epithelial cell motility on laminin-5: regulation by matrix assembly, proteolysis, integrins and erbB receptors. Matrix Biol 2004; 23: 75-85.
7. Katayama M, Seriguchiz K. Laminin-5 in epithelial tumour invasion. J Mol Histol 2004; 35: 277-86.
8. Givant-Horwitz V, Davidson B, Reich R. Laminin-induced signaling in tumor cells. Cancer Lett 2005; 223: 1-10.
9. Miyazaki K. Laminin-5 (laminin-332): unique biological activity and role in tumor growth and invasion. Cancer Sci 2006; 97: 91-8.
10. Marinkovich MP. Laminin 332 in squamous-cell carcinoma. Nat Rer Cancer 2007; 7: 370-80.
11. Patel V, Aldridge K, Ensley J, et al. Laminin-g2 overexpression in head-and-neck squamous cell Carcinoma. Int J Cancer 2002; 99: 583-8.
12. Aishima S, Matsuura S, Terashi T, et al. Aberrant expression of laminin gamma 2 chain and its prognostic significance in intrahepatic cholangiocarcinoma according to growth Morphology. Mod Pathol 2004; 17: 938-45.
13. Nilsson PJ, Rubio C, Lenander C, Auer G, Climelius B. Tumour budding detected by laminin-5 g2-chain immunohistochemistry is of prognostic value in epidermoid anal cancer. Ann Oncol 2005; 16: 893-8.
14. Baba Y, Lyama KI, Hirashima K, et al. Laminin-332 promotes the invasion of oesophageal squamous cell carcinoma via PI3K activation. Br J Cancer 2008; 98: 974-80.
15. Hamasaki H, Koga K, Aoki M, et al. Expression of laminin 5-g2 chain in cutaneous squamous cell carcinoma and its role in tumour invasion. Br J Cancer 2011; 105: 824-32.
16. Kim BG, An HJ, Kang S, et al. Laminin-332-Rich Tumor Microenvironment for Tumor Invasion in the Interface Zone of Breast Cancer. Am J Pathol 2011; 178: 373-81.
17. Ono Y, Nakanishi Y, Ino Y, et al. Clinicopathologic Significance of Laminin-5 γ2 Chain Expression in Squamous Cell Carcinoma of the Tongue. Cancer 1999; 85: 2315-21.
18. Kawano K, Yanagisawa S. Predictive value of laminin-5 and membrane type 1-matrix metalloproteinase expression for cervical lymph node metastasis in t1 and t2 squamous cell carcinomas of the tongue and floor of the mouth. Head Neck 2006; 28: 525-33.
19. Gasparoni A, Della Casa M, Milillo L, et al. Prognostic value of differential expression of Laminin-5 γ2 in oral squamous cell carcinomas: correlation with survival. Oncol Rep 2007; 18: 793-800.
20. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3: 349-62.
21. Eyden B. The myofibroblast. phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 2008; 12: 22-47.
22. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122: 103-11.
23. Desmoulière A, Guyot C, Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 2004; 48: 509-17.
24. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
25. Giatromanolaki A, Sivridis E, Koukourakis MI. The Pathology of Tumor Stromatogenesis. Cancer Biol Ther 2007; 6: 639-45.
26. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histophathology 2002; 40: 127-32.
27. Wang LM, Kevans D, Mulcahy H, et al. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am J Surg Pathol 2009; 33: 134-41.
28. Wang C, Huang H, Huang Z, et al. Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med 2011; 40: 545-51.
29. Kellermann MG, Sobral LM, da Silva SD, et al. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 2007; 51: 849-53.
30. De-Assis EM, Pimenta LG, Costa-e-Silva E, et al. Stromal myofibroblasts in oral leukoplakia and oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2012; 17: 733-8.
31. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
32. Liotta LA. Tumor invasion and metastases: role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 1986; 46: 1-7.
33. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3: 453-8.
34. Durbeej M. Laminins. Cell Tissue Res 2010; 339: 259-68.
35. Koshikawa N, Minegishi T, Sharabi A, Quaranta V, Seiki M. Membrane-type Matrix Metalloproteinase-1 (MT1-MMP) Is a Processing Enzyme for Human Laminin γ2 Chain. J Biol Chem 2005; 280: 88-93.
36. Richter P, Bohmer FD, Hindermann W, et al. Analysis of activated EGFR signalling pathways and their relation to laminin-5 γ2 chain expression in oral squamous cell carcinoma (OSCC). Histochem Cell Biol 2005; 124: 151-60.
37. Schenk S, Hintermann E, Bilban M, et al. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol 2003; 161: 197-209.
38. Franz M, Hansen T, Borsi L, et al. A quantitative co-localization analysis of large unspliced tenascin-CL and laminin-5/c2-chain in basement membranes of oral squamous cell carcinoma by confocal laser scanning microscopy. J Oral Pathol Med 2007a; 36: 6-11.
39. Franz M, Richter P, Geyer C, et al. Mesenchymal cells contribute to the synthesis and deposition of the laminin-5 c2 chain in the invasive front of oral squamous cell carcinoma. J Mol Histol 2007b; 38: 183-90.
40. Surowiak P, Suchocki S, Györffy B, et al. Stromal myofibroblasts in breast cancer: relations between their occurrence, tumor grade and expression of some tumour markers. Folia Histochem Cytobiol 2006; 44: 111-6.
41. Tsujino T, Seshimo I, Yamamoto H, et al. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 2007; 13: 2082-90.
42. Marsh D, Suchak K, Moutasim KA, et al. Stromal features are predictive of disease mortality in oral cancer patients. J Pathol 2011; 223: 470-81.
43. Koike M, Kodera Y, Itoh Y, et al. Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol 2008; 15: 1977-82.
44. Kanazawa H, Mitomi H, Nishiyama Y, et al. Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis 2007; 10: 41-7.
45. Sarioglu S, Acara C, Akman FC, et al. Tumor budding as a prognostic marker in laryngeal carcinoma. Pathol Res Pract 2010; 206: 88-92.
46. Masuda R, Kijima H, Imamura N, et al. Laminin-5γ2 chain expression is associated with tumor cell invasiveness and prognosis of lung squamous cell carcinoma. Biomed Res 2012; 33: 309-17.
47. Lindberg P, Larsson A, Nielsen BS. Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin gamma-2 chain is an early coordinated event in incipient oral squamous cell carcinoma. Int J Cancer 2006; 118: 2948-56.
48. Khanh DT, Mekata E, Mukaisho K, et al. Prognostic role of CD10+ myeloid cells in association with tumor budding at the invasion front of colorectal cancer. Cancer Sci 2011; 102: 1724-33.
49. Pyke C, Salo S, Ralfkiaer E, Rømer J, Danø K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995; 55: 4132-9.
50. Thorup AK, Dabelsteen E, Schou S, Gil SG, Carter WG, Reibel J. Differential expression of integrins and laminin-5 in normal oral epithelia. APMIS 1997; 105: 519-30.
51. Dabelsteen E, Grøn B, Mandel U, Mackenzie I. Altered expression of epithelial cell surface glycoconjugates and intermediate filaments at the margins of mucosal wounds. J Invest Dermatol 1998; 111: 592-7.
52. Wayner EA, Gil SG, Murphy GF, Wilke MS, Carter WG. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J Cell Biol 1993; 121: 1141-52.
53. Gil SG, Brown TA, Ryan MC, Carter WG. Junctional epidermolysis bullosis: defects in expression of epiligrin/nicein/kalinin and integrin beta 4 that inhibit hemidesmosome formation. J Invest Dermatol 1994; 103: 31S-8S.